相似文献
1
Posttreatment Symptoms in Lyme Borreliosis.
Clin Infect Dis. 2020 Dec 15;71(12):3125-3127. doi: 10.1093/cid/ciz1218.
2
Cutaneous manifestations of Lyme borreliosis.
Rheum Dis Clin North Am. 1989 Nov;15(4):627-34.
3
Skin manifestations of lyme borreliosis: diagnosis and management.
Am J Clin Dermatol. 2008;9(6):355-68. doi: 10.2165/0128071-200809060-00002.
4
First case of documented Lyme borreliosis in the Alpes-Maritimes department of South-Eastern France: Erythema chronicum migrans associated with Borrelia afzelii.
Ann Dermatol Venereol. 2022 Jun;149(2):146-147. doi: 10.1016/j.annder.2021.12.003. Epub 2022 Feb 17.
5
A two year prospective study to compare culture and polymerase chain reaction amplification for the detection and diagnosis of Lyme borreliosis.
Mol Pathol. 1997 Aug;50(4):186-93. doi: 10.1136/mp.50.4.186.
6
[Clinical manifestations, diagnosis and treatment of Lyme borreliosis].
Ugeskr Laeger. 2017 May 1;179(18).
7
[Lyme borreliosis with erythema chronicum migrans and Garin-Bujadoux-Bannwarth meningopolyneuritis].
Z Gesamte Inn Med. 1989 Nov 1;44(21):658-60.
8
Isolation and species typing of Lyme borreliosis spirochaetes from UK patients with erythema migrans.
Eur J Epidemiol. 1999 May;15(5):499-500. doi: 10.1023/a:1007591501411.
9
Association between different clinical manifestations of Lyme disease and different species of Borrelia burgdorferi sensu lato.
Res Microbiol. 1995 May;146(4):329-40. doi: 10.1016/0923-2508(96)81056-4.
10
[From tick bite to borreliosis: the dreaded small blood sucker].
MMW Fortschr Med. 2011 Jun 2;153(22):14-7. doi: 10.1007/BF03368461.
引用本文的文献
1
Diagnostic probability classification in suspected borreliosis by a novel C6-peptide IgG1- subclass antibody test.
Front Cell Infect Microbiol. 2023 Sep 11;13:1108115. doi: 10.3389/fcimb.2023.1108115. eCollection 2023.
2
Lyme Disease in Humans.
Curr Issues Mol Biol. 2021;42:333-384. doi: 10.21775/cimb.042.333. Epub 2020 Dec 11.
本文引用的文献
1
Prospective Evaluation of the Frequency and Severity of Symptoms in Lyme Disease Patients With Erythema Migrans Compared With Matched Controls at Baseline, 6 Months, and 12 Months.
Clin Infect Dis. 2020 Dec 15;71(12):3118-3124. doi: 10.1093/cid/ciz1215.
2
Clinical Course, Serologic Response, and Long-Term Outcome in Elderly Patients with Early Lyme Borreliosis.
J Clin Med. 2018 Dec 2;7(12):506. doi: 10.3390/jcm7120506.
3
Comparison of Clinical Course and Treatment Outcome for Patients With Early Disseminated or Early Localized Lyme Borreliosis.
JAMA Dermatol. 2018 Sep 1;154(9):1050-1056. doi: 10.1001/jamadermatol.2018.2306.
4
Oral doxycycline versus intravenous ceftriaxone for treatment of multiple erythema migrans: an open-label alternate-treatment observational trial.
J Antimicrob Chemother. 2018 May 1;73(5):1352-1358. doi: 10.1093/jac/dkx534.
5
CCL19 as a Chemokine Risk Factor for Posttreatment Lyme Disease Syndrome: a Prospective Clinical Cohort Study.
Clin Vaccine Immunol. 2016 Sep 6;23(9):757-66. doi: 10.1128/CVI.00071-16. Print 2016 Sep.
6
Randomized Trial of Longer-Term Therapy for Symptoms Attributed to Lyme Disease.
N Engl J Med. 2016 Mar 31;374(13):1209-20. doi: 10.1056/NEJMoa1505425.
7
Elevated levels of IL-23 in a subset of patients with post-lyme disease symptoms following erythema migrans.
Clin Infect Dis. 2014 Feb;58(3):372-80. doi: 10.1093/cid/cit735. Epub 2013 Nov 11.
8
Anti-neural antibody reactivity in patients with a history of Lyme borreliosis and persistent symptoms.
Brain Behav Immun. 2010 Aug;24(6):1018-24. doi: 10.1016/j.bbi.2010.03.002. Epub 2010 Mar 18.
9
Subjective symptoms after treatment of early Lyme disease.
Am J Med. 2010 Jan;123(1):79-86. doi: 10.1016/j.amjmed.2009.05.011.
10
A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy.
Neurology. 2008 Mar 25;70(13):992-1003. doi: 10.1212/01.WNL.0000284604.61160.2d. Epub 2007 Oct 10.
Zotero 插件